Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Stanford, California 94305


Purpose:

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.


Study summary:

It is thought that studies of genetic reprogramming and SCNT using human cells have the potential to give us new basic knowledge about human development. Current work will focus on developing this basic knowledge. In the future, human embryonic stem cell lines (hESC) derived from genetic reprogramming and SCNT may also have the potential to develop into cell types that are useful for cell-based therapies to treat human disease and disability.


Criteria:

Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure) Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.


Study is Available At:


Original ID:

SU-12202007-950


NCT ID:

NCT00628199


Secondary ID:


Study Acronym:


Brief Title:

Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability


Official Title:

Derivation of Primary Donor Cell Lines for Human Cell Reprogramming


Overall Status:

Enrolling by invitation


Study Phase:

N/A


Genders:

Both


Minimum Age:

1 Year


Maximum Age:

75 Years


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Stanford University


Oversight Authority:

  • United States: Food and Drug Administration
  • United States: Institutional Review Board


Reasons Why Stopped:


Study Type:

Observational


Study Design:

Time Perspective: Prospective


Number of Arms:

0


Number of Groups:

0


Total Enrollment:

60


Enrollment Type:

Anticipated


Overall Contact Information

Official Name:Renee A. Reijo Pera
Principal Investigator
Stanford University

Study Dates

Start Date:September 2007
Primary Completion Date:January 2010
Primary Completion Type:Anticipated
Verification Date:February 2009
Last Changed Date:February 20, 2009
First Received Date:February 22, 2008

Study Outcomes

There are no available Study Outcomes

Study Interventions

Intervention Type:Procedure
Name:Improving the scientific process of human cell rep

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:Stanford University

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.